// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























2187 Abstracts

CLINICOBIOLOGIC CHARACTERISTICS AND OUTCOME OF ELDERLY FRAIL PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA INCLUDED IN A SPECIFIC PROTOCOL (ALL-07FRAIL)

Josep Maria Ribera - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Allmercap

MONOCYTIC SWITCH AND DISCREPANCY BETWEEN FLOW CYTOMETRIC AND MOLECULAR MINIMAL RESIDUAL DISEASE ARE FREQUENT IN DUX4 REARRANGED AND PAX5-P80R MUTATED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Michaela Novakova - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

NATION-WIDE PROSPECTIVE, REAL-TIME MONITORING OF PEGYLATED E.COLI AND ERWINIA ASPARAGINASE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA IN BELGIUM

Veerle Mondelaers - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

Erwinase

DEFINITION OF REPRESENTATIVE BONE MARROW SAMPLE BASED ON PARALLEL EVALUATION OF PERIPHERAL BLOOD DURING THE THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA

Barbora Vakrmanova - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

THE SIGNIFICANCE OF MONOSOMAL KARYOTYPE IN PHILADELPHIA CHROMOSOME NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA

Zongru Li - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Allmercap

PEDIATRIC-INSPIRED REGIMEN PLUS HDACI CHIDAMIDE YIELDED PROMISING RESPONSE IN PH-LIKE AND ETP ACUTE LYMPHOBLASTIC LEUKEMIA

Hongsheng Zhou - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Pegaspargase

EFFICACY OF CONSOLIDATION CHEMOTHERAPY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO ACHIEVED COMPLETE REMISSION BY FIRST COURSE OF REMISSION INDUCTION THERAPY.

Akio Shigematsu - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

INTENSIVE CARE OF THE LIFE -THREATING COMPLICATION DE NOVO ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS (PTS)

Aleksei Bazhenov - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

PLASMA LEVELS AND OUTCOMES OF PROPHYLACTIC POST-TRANSPLANT PONATINIB ADMINISTRATION IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Satoru Nanno - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Ponatinib

NO BLASTS AT DAY 8 IS BETTER THAN MORE IN CORTICO-SENSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDREN

Imen Frikha - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

EVALUATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY AS PROGNOSTIC MARKERS IN A PEDIATRIC PATIENT COHORT WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Monika Haubitz - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

THE IMPACT OF COMORBIDITY ON SURVIVAL OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Roberta Demichelis - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lymphoblastic leukemia

N/A

FEASIBILITY AND OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANTATION IN ADULT PHI NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA.

Yousra Fakhfakh - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lymphoblastic leukemia

N/A

SUCCESSFUL HAPLOIDENTIC BONE MARROW TRANSPLANTATION WITH INOTUZUMAB OZOGAMICIN IN PATIENT WITH RELAPSED AND RESISTANT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Ali nal - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Inotuzumab ozogamicin

TREATMENT OF FAVORABLE RISK YOUNG PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) USING A LOW-DENSE/ LOW-INTENSE CHEMOTHERAPY PROTOCOL

Maher Salamoon - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

Cyclophosphamide

WHERE IS THE PLACE OF PET/CT IN DIAGNOSTIC IN PATIENTS WITH LYMPHOBLASTIC LYMPHOMA AND ACUTE LYMPHOBLASTIC LEUKEMIA WITH EXTRAMEDULLARY INVOLVEMENT?

Olga Gavrilina - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

EARLY T-CELL PRECURSOR (ETP) ACUTE LYMPHOBLASTIC LEUKEMIA (ETP-ALL) IN ADOLESCENTS AND ADULTS: A HIGH-RISK SUBTYPE

SL Chong - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

RISK FACTORS FOR THROMBOEMBOLISM IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Ana Boban - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute lymphoblastic leukemia

N/A

REVIEW OF BLOODSTREAM INFECTION IN ADULT PATIENTS OF ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH HYPERCVAD – A TERTIARY CENTRE EXPERIENCE

Shun Yin Kong - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

Piperacillin/tazobactam

ASSESSMENT OF SERUM IL-15 IN ADULT ACUTE LEUKEMIA PATIENTS (EGYPTIAN SAMPLE)

Mohamed Mahmoud Moussa - European Hematology Association (EHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Acute lymphoblastic leukemia

IL-15

Copyright © 2026. QuantiNova All rights reserved